Site for Multicenter Randomized Pragmatic Clinical Trial Comparing Two- Versus Three-Antibiotic Therapy for Pulmonary Mycobacterium avium Complex Disease
Brief description of study
Site for To determine whether 2-drug is non-inferior to 3-drug (standard) therapy against pulmonary Mycobacterium avium complex (MAC) and whether 2-drug therapy is better tolerated than 3-drug therapy.
Clinical Study Identifier: s19-00328
ClinicalTrials.gov Identifier: NCT03672630
Principal Investigator:
Doreen J Addrizzo-Harris.
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.